Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Karl Reitzle"'
Autor:
Michael Frey, Lukasz Smigielski, Elvira Tini, Stefanie Fekete, Christian Fleischhaker, Christoph Wewetzer, Andreas Karwautz, Christoph U. Correll, Manfred Gerlach, Regina Taurines, Paul L. Plener, Uwe Malzahn, Selina Kornbichler, Laura Weninger, Matthias Brockhaus, Su-Yin Reuter-Dang, Karl Reitzle, Hans Rock, Hartmut Imgart, Peter Heuschmann, Stefan Unterecker, Wolfgang Briegel, Tobias Banaschewski, Jörg M. Fegert, Tobias Hellenschmidt, Michael Kaess, Michael Kölch, Tobias Renner, Christian Rexroth, Susanne Walitza, Gerd Schulte-Körne, Marcel Romanos, Karin Maria Egberts
Publikováno v:
Pharmaceutics, Vol 15, Iss 9, p 2202 (2023)
Fluoxetine is the recommended first-line antidepressant in many therapeutic guidelines for children and adolescents. However, little is known about the relationships between drug dose and serum level as well as the therapeutic serum reference range i
Externí odkaz:
https://doaj.org/article/204809af7ca7493e9484cd39644b9394
Autor:
Elvira Tini, Lukasz Smigielski, Marcel Romanos, Christoph Wewetzer, Andreas Karwautz, Karl Reitzle, Christoph U. Correll, Paul L. Plener, Uwe Malzahn, Peter Heuschmann, Stefan Unterecker, Maike Scherf-Clavel, Hans Rock, Gisela Antony, Wolfgang Briegel, Christian Fleischhaker, Tobias Banaschewski, Tobias Hellenschmidt, Hartmut Imgart, Michael Kaess, Michael Kölch, Tobias Renner, Su-Yin Reuter-Dang, Christian Rexroth, Gerd Schulte-Körne, Frank Theisen, Stefanie Fekete, Regina Taurines, Manfred Gerlach, Karin Maria Egberts, Susanne Walitza
Publikováno v:
Comprehensive Psychiatry, Vol 115, Iss , Pp 152301- (2022)
Background: Sertraline is a selective serotonin reuptake inhibitor with specific indications in child and adolescent psychiatry. Notwithstanding its frequent use and clinical benefits, the relationship between pharmacokinetics, pharmacodynamics, effi
Externí odkaz:
https://doaj.org/article/3f307d4ad67e41c2953892d0473505e5
Autor:
Karin M. Egberts, Manfred Gerlach, Christoph U. Correll, Paul L. Plener, Uwe Malzahn, Peter Heuschmann, Stefan Unterecker, Maike Scherf-Clavel, Hans Rock, Gisela Antony, Wolfgang Briegel, Christian Fleischhaker, Alexander Häge, Tobias Hellenschmidt, Harmut Imgart, Michael Kaess, Andreas Karwautz, Michael Kölch, Karl Reitzle, Tobias Renner, Su-Yin Reuter-Dang, Christian Rexroth, Gerd Schulte-Körne, Frank M. Theisen, Susanne Walitza, Christoph Wewetzer, Stefanie Fekete, Regina Taurines, Marcel Romanos
Publikováno v:
Egberts, Karin M.; Gerlach, Manfred; Correll, Christoph U.; Plener, Paul L.; Malzahn, Uwe; Heuschmann, Peter; Unterecker, Stefan; Scherf-Clavel, Maike; Rock, Hans; Antony, Gisela; Briegel, Wolfgang; Fleischhaker, Christian; Häge, Alexander; Hellenschmidt, Tobias; Imgart, Harmut; Kaess, Michael; Karwautz, Andreas; Kölch, Michael; Reitzle, Karl; Renner, Tobias; ... (2022). Serious Adverse Drug Reactions in Children and Adolescents Treated On-and Off-Label with Antidepressants and Antipsychotics in Clinical Practice. Pharmacopsychiatry, 55(05), pp. 255-265. Thieme 10.1055/a-1716-1856
Introduction Despite the growing evidence base for psychotropic drug treatment in pediatric patients, knowledge about the benefit-risk ratio in clinical practice remains limited. The ‘Therapeutic Drug Monitoring (TDM)-VIGIL’ study aimed to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fa63a58a5408fdfdb5874125246246
Autor:
Karl Reitzle, Michael Roth, Peter Scheuerpflug, Nicole Peschke, Claudia Mehler-Wex, Andreas Warnke
Publikováno v:
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie. 33:285-293
Zusammenfassung: Fragestellung: Diagnostische und klinische Faktoren sowie Behandlungsstrategien als prognostische Indikatoren für den Langzeitverlauf der Enkopresis im Kindes- und Jugendalter. Methodik: 85 Kinder und Jugendliche (Alter 9,6 ± 3,2 J
Autor:
Claudia, Mehler-Wex, Peter, Scheuerpflug, Nicole, Peschke, Michael, Roth, Karl, Reitzle, Andreas, Warnke
Publikováno v:
Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie. 33(4)
comparison of diagnostic, clinical and therapeutic features and their predictive value for the outcome of encopresis in children and adolescents.85 children and adolescents (aged 9.6 +/- 3.2 years) with severe encopresis (ICD 10: F98.1) were investig